|
BR9606546A
(pt)
|
1995-08-02 |
1998-07-14 |
Uriach & Cia Sa J |
Novas carboxamidas com atividade fungicida
|
|
US6218387B1
(en)
|
1996-12-20 |
2001-04-17 |
Hoechst Aktiengesellschaft |
Vitronectin receptor anatagonists, their preparation and their use
|
|
US6723727B1
(en)
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
|
EP1664026B1
(en)
|
2003-08-15 |
2009-01-21 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
JP2007502773A
(ja)
|
2003-08-15 |
2007-02-15 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害薬
|
|
US7112316B1
(en)
|
2005-08-08 |
2006-09-26 |
Uop Llc |
Process for preparing molecular sieves via continuous addition of nutrients
|
|
EP1984355A2
(en)
|
2006-02-16 |
2008-10-29 |
Takeda Pharmaceutical Company Limited |
Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
|
|
AU2008302746B2
(en)
|
2007-09-20 |
2014-07-03 |
Amgen Inc. |
1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as SlP receptor modulators for the treatment of immune disorders
|
|
ES2524883T3
(es)
|
2008-03-18 |
2014-12-15 |
Merck Sharp & Dohme Corp. |
4-Hidroxipirimidina-5-carboxamidas sustituidas
|
|
US9278922B2
(en)
|
2009-04-15 |
2016-03-08 |
Abbvie Inc. |
Anti-viral compounds
|
|
US8653172B2
(en)
|
2010-03-17 |
2014-02-18 |
Exxonmobil Chemical Patents Inc. |
Plasticiser blends and compositions and articles made therefrom
|
|
JP5947307B2
(ja)
|
2010-10-20 |
2016-07-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
Ｋｃｎｑ２／３調節因子としての置換６−アミノ−ニコチンアミド
|
|
WO2013049255A1
(en)
|
2011-09-26 |
2013-04-04 |
Vanderbilt University |
Substitued 5-(prop-1-yn-1-yl)picolinamide analogs as allosteric modulators of mglur5 receptors
|
|
TWI637951B
(zh)
|
2013-02-15 |
2018-10-11 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺類
|
|
GEAP201814220A
(en)
|
2013-12-24 |
2018-03-12 |
Oncotartis Inc |
Benzamide and nicotinamide compounds and methods of using same
|
|
KR101555033B1
(ko)
|
2014-07-28 |
2015-09-23 |
충남대학교산학협력단 |
신규한 메타논 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물
|
|
KR101551313B1
(ko)
|
2014-07-28 |
2015-09-09 |
충남대학교산학협력단 |
신규한 인덴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물
|
|
CN106573006A
(zh)
|
2014-08-21 |
2017-04-19 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为药物的rip1激酶抑制剂杂环酰胺
|
|
WO2016101885A1
(en)
|
2014-12-24 |
2016-06-30 |
National Institute Of Biological Sciences, Beijing |
Necrosis inhibitors
|
|
TWI730959B
(zh)
|
2015-05-19 |
2021-06-21 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺
|
|
EP3317269B1
(en)
|
2015-07-02 |
2022-09-21 |
F. Hoffmann-La Roche AG |
Bicyclic lactams as receptor-interacting protein-1 (rip1) kinase inhibitors for treating e.g. inflammatory diseases
|
|
AU2016340527B2
(en)
|
2015-10-23 |
2020-09-17 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
WO2017096301A1
(en)
|
2015-12-04 |
2017-06-08 |
Denali Therapeutics Inc. |
Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (ripk 1)
|
|
US10961258B2
(en)
|
2015-12-21 |
2021-03-30 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides as kinase inhibitors
|
|
IL287136B2
(en)
|
2016-02-05 |
2023-09-01 |
Denali Therapeutics Inc |
Receptor inhibitors - interacting with protein kinase 1
|
|
JP7121731B2
(ja)
|
2016-09-26 |
2022-08-18 |
タフツ・ユニバーシティ |
ウリジンヌクレオシド誘導体、組成物及び使用方法
|
|
EP3580220B1
(en)
|
2017-02-13 |
2021-11-17 |
Bristol-Myers Squibb Company |
Aminotriazolopyridines as kinase inhibitors
|
|
DE102017211104B3
(de)
|
2017-06-29 |
2018-10-18 |
Bundesdruckerei Gmbh |
Verfahren und Vorrichtung zum Verifizieren eines elektrolumineszierenden Sicherheitsmerkmals in einem Wert- oder Sicherheitsdokument unter Ausnutzung von zusätzlicher Lichtstrahlung
|
|
HRP20231381T1
(hr)
|
2018-05-03 |
2024-03-01 |
Rigel Pharmaceuticals, Inc. |
Spojevi inhibitori rip1 i postupci za njihovo dobivanje i upotrebu
|
|
JP7162372B2
(ja)
*
|
2018-07-02 |
2022-10-28 |
深▲チェン▼市塔吉瑞生物医薬有限公司 |
キナーゼ活性を阻害するためのアルキニル（ヘテロ）芳香族化合物
|
|
WO2020013531A1
(ko)
|
2018-07-10 |
2020-01-16 |
보로노이바이오 주식회사 |
N-(3-(이미다조[1,2-b]피리다진-3-일에티닐)-4-메틸페닐)-5-페닐-4,5-다이하이드로-1H-피라졸-1-카복사마이드 유도체 및 이를 유효성분으로 포함하는 키나아제 관련 질환 치료용 약학적 조성물
|
|
WO2020149553A1
(ko)
*
|
2019-01-15 |
2020-07-23 |
주식회사 보로노이 |
아릴 또는 헤테로아릴 유도체, 및 이를 유효성분으로 포함하는 키나아제 관련 질환 치료용 약학적 조성물
|
|
CN117460722A
(zh)
|
2021-08-10 |
2024-01-26 |
艾伯维公司 |
烟酰胺ripk1抑制剂
|